Cheng X - Search Results

1

TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase.

Xu S, Wu X, Wang S, Xu M, Fang T, Ma X, Chen M, Fu J, Guo J, Tian S, Tian T, Cheng X, Yang H, Zhou J, Wang Z, Yin Y, Xu W, Xu F, Yan J, Wang Z, Luo S, Zhang XJ, Ji YX, Weng J. Xu S, et al. Among authors: cheng x. J Clin Invest. 2024 Jan 11;134(5):e166149. doi: 10.1172/JCI166149. J Clin Invest. 2024. PMID: 38206764 Free PMC article.

2

An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.

Zhang XJ, Cheng X, Yan ZZ, Fang J, Wang X, Wang W, Liu ZY, Shen LJ, Zhang P, Wang PX, Liao R, Ji YX, Wang JY, Tian S, Zhu XY, Zhang Y, Tian RF, Wang L, Ma XL, Huang Z, She ZG, Li H. Zhang XJ, et al. Among authors: cheng x. Nat Med. 2018 Jan;24(1):73-83. doi: 10.1038/nm.4451. Epub 2017 Dec 11. Nat Med. 2018. PMID: 29227475

3

Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice.

Tong J, Han CJ, Zhang JZ, He WZ, Zhao GJ, Cheng X, Zhang L, Deng KQ, Liu Y, Fan HF, Tian S, Cai J, Huang Z, She ZG, Zhang P, Li H. Tong J, et al. Among authors: cheng x. Hepatology. 2019 Jun;69(6):2471-2488. doi: 10.1002/hep.30559. Epub 2019 Apr 22. Hepatology. 2019. PMID: 30748020

4

Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.

Fang J, Ji YX, Zhang P, Cheng L, Chen Y, Chen J, Su Y, Cheng X, Zhang Y, Li T, Zhu X, Zhang XJ, Wei X. Fang J, et al. Among authors: cheng x, cheng l. Hepatology. 2020 May;71(5):1592-1608. doi: 10.1002/hep.30950. Epub 2020 Jan 30. Hepatology. 2020. PMID: 31529495

5

TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.

Liu D, Zhang P, Zhou J, Liao R, Che Y, Gao MM, Sun J, Cai J, Cheng X, Huang Y, Chen G, Nie H, Ji YX, Zhang XJ, Huang Z, Xu H, She ZG, Li H. Liu D, et al. Among authors: cheng x. Cell Metab. 2020 Apr 7;31(4):726-740.e8. doi: 10.1016/j.cmet.2020.03.007. Cell Metab. 2020. PMID: 32268115 Free article.

6

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.

Jian C, Fu J, Cheng X, Shen LJ, Ji YX, Wang X, Pan S, Tian H, Tian S, Liao R, Song K, Wang HP, Zhang X, Wang Y, Huang Z, She ZG, Zhang XJ, Zhu L, Li H. Jian C, et al. Among authors: cheng x. Cell Metab. 2020 May 5;31(5):892-908.e11. doi: 10.1016/j.cmet.2020.04.011. Cell Metab. 2020. PMID: 32375062 Free PMC article.

7

Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD.

Yang X, Sun D, Xiang H, Wang S, Huang Y, Li L, Cheng X, Liu H, Hu F, Cheng Y, Ma T, Hu M, Tian H, Tian S, Zhou Y, Zhang P, Zhang XJ, Ji YX, Hu Y, Li H, She ZG. Yang X, et al. Among authors: cheng y, cheng x. Hepatology. 2021 Sep;74(3):1319-1338. doi: 10.1002/hep.31863. Epub 2021 Aug 30. Hepatology. 2021. PMID: 33894019

8

A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis.

Ji YX, Wang Y, Li PL, Cai L, Wang XM, Bai L, Liu Z, Tian H, Tian S, Zhang P, Zhang XJ, Cheng X, Yuan Y, She ZG, Hu Y, Li H. Ji YX, et al. Among authors: cheng x. Cell Metab. 2021 Jun 1;33(6):1171-1186.e9. doi: 10.1016/j.cmet.2021.04.006. Epub 2021 May 4. Cell Metab. 2021. PMID: 33951476 Free article.

9

TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease.

Zhao GN, Tian ZW, Tian T, Zhu ZP, Zhao WJ, Tian H, Cheng X, Hu FJ, Hu ML, Tian S, Ding T, Chen S, Ji YX, Zhang P, Zhang XJ, She ZG, Yuan Y, Chen W, Bai L, Li H. Zhao GN, et al. Among authors: cheng x. Cell Metab. 2021 Aug 3;33(8):1640-1654.e8. doi: 10.1016/j.cmet.2021.05.014. Epub 2021 Jun 8. Cell Metab. 2021. PMID: 34107313 Free article.

10

TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.

Zhou J, Hu M, He M, Wang X, Sun D, Huang Y, Cheng X, Fu J, Cai J, Ma T, Tian S, Hu Y, Hu F, Liu D, He Y, Yan L, She ZG, Zhang XJ, Ji YX, Liu H, Li H, Yang H, Zhang P. Zhou J, et al. Among authors: cheng x. Hepatology. 2021 Oct;74(4):2133-2153. doi: 10.1002/hep.32015. Epub 2021 Aug 30. Hepatology. 2021. PMID: 34133792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,852 results

Search Page